-
Lung cancer and the spread of the disease are characterized by geno-transcriptomic evolution
The simulated tumour is then ‘Sampled’ in 8 regions of around 50,000 cells. mRNA coverage for single nucleotide variants (SNVs) detected in matched whole-exome sequencing data was calculated for three cancer-specific gene sets. RNA coverage was calculated for single nucleotide variants found in matched whole-exome sequencing data per tumour region using SAMTools (v.1.9)61 mpileup.
-
Sucralose is a negative modulator of T cell-mediated responses
Tumour weight was measured at day 20 after tumour cell injection as per ImageJ v.2.1.0/1.53c. On the very next day, Bone Marrow cells isolated from wild-types were transferred to Mpo–/– mice. Tumour weight was assessed at day 17 after tumour cell injection unless otherwise indicated. T cells isolated from C57BL/6J male mice aged between 6…
-
Individualized treatments are paving the way thanks to the success of the CRISPR cancer trial.
A researcher at the University of Pennsylvania has said that a CAR-T-cell therapy that harnesses an individual’s own T cells is not the same as in other diseases. Joseph Fraietta said, “Solid tumours provide barriers to T cells, which have to move through the blood to kill the cancer cells.” He added, “In three years,…